Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Dake

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|November 11, 2017
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels-Results from the Zilver PTX Japan Post-Market Surveillance StudyStefano Cipollari, Hiroyoshi Yokoi, Takao Ohki, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 8, 2014
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trialsTakao Ohki, Hiroyoshi Yokoi, Kimihiko Kichikawa, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 21, 2020
Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance StudyMasayuki Sugimoto, Kimihiro Komori, Hiroyoshi Yokoi, et al.
Cardiovascular and Interventional Radiology|November 10, 2018
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year ResultsKimihiko Kichikawa, Shigeo Ichihashi, Hiroyoshi Yokoi, et al.
Cardiovascular and Interventional Radiology|May 11, 2017
Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in JapanYukihisa Ogawa, Hiroyoshi Yokoi, Takao Ohki, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 14, 2020
Improved midterm outcomes after endovascular repair of nontraumatic descending thoracic aortic rupture compared with open surgeryYukihisa Ogawa, A Claire Watkins, Bharathi Lingala, et al.
Cardiovascular and Interventional Radiology|October 7, 2020
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral StentMichael D Dake, Fabrizio Fanelli, Aaron E Lottes, et al.
Journal of Vascular Surgery|May 3, 2021
Evaluation of the Gore TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysmsMichael D Dake, Michael P Fischbein, Joseph E Bavaria, et al.
Frontiers in Cardiovascular Medicine|October 14, 2022
First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China studyWei Ye, Tanja Böhme, Weiguo Fu, et al.
Journal of the American College of Cardiology|April 16, 2013
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studiesMichael D Dake, Gary M Ansel, Michael R Jaff, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Journal of Vascular and Interventional Radiology : JVIR|November 11, 2017
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels-Results from the Zilver PTX Japan Post-Market Surveillance StudyStefano Cipollari, Hiroyoshi Yokoi, Takao Ohki, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 8, 2014
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trialsTakao Ohki, Hiroyoshi Yokoi, Kimihiko Kichikawa, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 21, 2020
Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance StudyMasayuki Sugimoto, Kimihiro Komori, Hiroyoshi Yokoi, et al.
Cardiovascular and Interventional Radiology|November 10, 2018
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year ResultsKimihiko Kichikawa, Shigeo Ichihashi, Hiroyoshi Yokoi, et al.
Cardiovascular and Interventional Radiology|May 11, 2017
Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in JapanYukihisa Ogawa, Hiroyoshi Yokoi, Takao Ohki, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 14, 2020
Improved midterm outcomes after endovascular repair of nontraumatic descending thoracic aortic rupture compared with open surgeryYukihisa Ogawa, A Claire Watkins, Bharathi Lingala, et al.
Cardiovascular and Interventional Radiology|October 7, 2020
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral StentMichael D Dake, Fabrizio Fanelli, Aaron E Lottes, et al.
Journal of Vascular Surgery|May 3, 2021
Evaluation of the Gore TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysmsMichael D Dake, Michael P Fischbein, Joseph E Bavaria, et al.
Frontiers in Cardiovascular Medicine|October 14, 2022
First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China studyWei Ye, Tanja Böhme, Weiguo Fu, et al.
Journal of the American College of Cardiology|April 16, 2013
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studiesMichael D Dake, Gary M Ansel, Michael R Jaff, et al.
Pageof 18